ELAN vs MRVL · rev $2.74B vs P/E 100, rev $5.16B
Elanco Animal Health (ELAN) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
ELAN currently screens at market cap $11.80B. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the ELAN and MRVL stock pages for the full models.
Not investment advice.